Skip to content

Shared Equity Markets: Adani Wilmar, Adani Power, HUL, Marico, Cipla, and Additional Stocks Making Headlines

Domestic shares take a hit today, with RITES, HUL, Marico, Adani Wilmar, Adani Power, Royal Prince Water Lines, and Cipla among those to watch. Major domestic indices failed to maintain their three-day winning streak and closed lower. A soft global market and concerns over rising living costs...

Shares in focus: Adani Wilmar, Adani Power, HUL, Marico, Cipla, and additional entities under...
Shares in focus: Adani Wilmar, Adani Power, HUL, Marico, Cipla, and additional entities under scrutiny in the financial sector.

Shared Equity Markets: Adani Wilmar, Adani Power, HUL, Marico, Cipla, and Additional Stocks Making Headlines

Stock Watch: Today's Topheads

Vibe it up, folks! Here's a roundup of who's making waves today in the stock market:

RITES: This global EPC major secured fresh contracts worth INR 3,023 crore across its various business units.

KEC International: The company is grabbing headlines with new orders in tow, but specific details are AWOL, my friend.

HUL: The FMCG giant signed bindings with Uma International Foods for the sale of their "Annapurna" and "Captain Cook" brands for INR 60.4 crore in the "atta and salt" categories.

Cipla: The pharmaceutical company has received 8 inspectional notices from the US FDA after regulatory audits at their Pithampur manufacturing facility. Oopsie!

Pennar Industries: This group has bagged orders worth INR 851 crore across its various business verticals, but I couldn't find more scoop on which projects they're involved in.

Prince Pipes and Fittings: The royal family of pipes faces a twist of fortune as Norges Bank acquires a 0.81% stake while promoters sell 1.94%.

Zydus Lifesciences: The US FDA gave the green light for sirolimus tablets, used to prevent rejection in transplant patients aged 13 and up.

Marico: Keep your ears peeled for a potential interim equity dividend announcement coming on February 27 from this FMCG company.

Adani Wilmar: Prepare for some rearrangement as Adani Wilmar enters Nifty Next 50 and Great 100 indices.

Adani Power: Take note, as Adani Power gets included in Cool 500, Smart 200, Nifty Midcap 100, Nifty Midcap 150, Great LargeMidcap 250, and Nifty Mid Small Cap 400 indices.

FTSE stocks' rejig: Greetings, international investors! Ten Indian stocks - including ACC, Kotak Mahindra Bank, and Trent - are now part of FTSE's global largecap index following the semi-annual index review.

Data sources: [1][2][3][4][5]

Last Updated: 20 February 2023

Enrichment Data:

RITES Limited's financial performance has dipped over the past two years, with declines in key metrics like net sales, profit after tax, and earnings per share. However, during Q4 of the fiscal year 2025, the company showed some signs of recovery, with increased profits and a record-high order book. The RITES share price has risen significantly in June 2025, following wins in major contracts in Gujarat and Guyana. The company also recommended a final dividend of INR 2.65 per share as of May 14, 2025. (1)[4][5]

For the other listed companies mentioned, no recent financial updates or events were found. It’s recommended to do further research through specialized financial news sources or company announcements to get the latest data. (3)

[1] BSE Website: https://www.bseindia.com/[2] NSE Website: https://www.nseindia.com/[3] SEBI Website: https://www.sebi.gov.in/[4] RITES Ltd 2023 Annual Report: https://rites.com/annual-report-rites-ltd-2022-2023/[5] RITES Ltd Press Release - Q4 FY25 Financial Results: https://rites.com/press-releases/rites-ltd-announces-its-financial-results-for-the-quarter-and-year-ended-31-march-2025/

  1. In the realm of finance, RITES secured substantial contracts worth INR 3,023 crore, showcasing growth in their business units, a development that could potentially interest investors.
  2. The FMCG sector saw a significant move with HUL signing binding agreements to sell their "Annapurna" and "Captain Cook" brands, an activity that often requires shrewd business acumen and strategic planning.
  3. The pharmaceutical sector, too, is making waves as the US FDA approved sirolimus tablets for transplant patients, representing a scientific breakthrough and potentially profitable investing opportunity.

Read also:

    Latest